Skip to main content
DANAHER CORP /DE/ logo

DANAHER CORP /DE/ — Investor Relations & Filings

Ticker · DHR ISIN · US2358511028 LEI · S4BKK9OTCEWQ3YHPFM11 US Manufacturing
Open in API
Filings indexed 2,519 across all filing types
Latest filing 2026-06-08 Regulatory Filings
Country US United States of America
Listing US DHR

About DANAHER CORP /DE/

https://www.danaher.com/

Danaher Corporation is a global science and technology company focused on improving human health. It operates across three primary segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment provides technologies and services to accelerate the development and commercialization of therapies, including biologics and cell and gene therapies. The Life Sciences segment offers tools and technologies that support scientific research and laboratory activities in areas such as molecular oncology and fluid filtration. The Diagnostics segment develops instruments, software, and reagents designed to deliver precise and rapid medical diagnoses. A core component of its strategy is the Danaher Business System (DBS), a proprietary management system that drives continuous improvement and operational excellence across its portfolio of businesses.

Recent filings

Filing Released Lang Actions
S-8
Regulatory Filings Classification · 85% confidence The document is a Registration Statement on SEC Form S-8 under the Securities Act of 1933, which registers shares for an equity incentive plan following a merger. This is a regulatory filing that does not fit into other categories like Annual Report, Proxy, Earnings Release, or Share Issue announcement. Form S-8 registrations fall under general regulatory filings. Therefore, the appropriate classification is RNS (Regulatory Filings).
2026-06-08 English
S-8
Regulatory Filings Classification · 87% confidence The document is a Form S-8 registration statement filed with the SEC to register additional shares under an employee incentive plan. It is not an annual or interim report, proxy, earnings release, or other specific category defined, but a regulatory filing under the Securities Act of 1933. Therefore it falls under the general “Regulatory Filings” category (RNS) as a fallback for SEC registration statements not covered by a more specific code.
2026-06-08 English
8-K
Capital/Financing Update Classification · 90% confidence The document is a Form 8-K current report disclosing the issuance of multiple series of senior notes (private placement of debt), detailing principal amounts, maturities, interest rates, and use of proceeds. This constitutes an update on the company’s fundraising and capital structure. Therefore, it fits the Capital/Financing Update category.
2026-06-03 English
SD - DANAHER CORP /DE/ (0000313616) (Filer)
Regulatory Filings Classification · 87% confidence The document is a Form SD (Specialized Disclosure Report) filed under Rule 13p–1 for conflict minerals. It is not an annual or interim financial report, earnings release, management discussion, proxy, or capital transaction. It is a specialized SEC disclosure form without substantive financial statements. As such, it does not fit any specific category except the general regulatory announcements or filings. Therefore, it is classified as a Regulatory Filing (RNS).
2026-05-12 English
8-K - DANAHER CORP /DE/ (0000313616) (Filer)
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K Current Report containing the official voting results from the company’s annual meeting (election of directors, ratification of auditors, advisory vote on compensation, and approval of the incentive plan). This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official shareholder vote outcomes at general meetings.
2026-05-07 English
NYSE CERTIFICATION
Regulatory Filings Classification · 85% confidence The document is a certification letter from the New York Stock Exchange to the SEC approving the listing and registration of certain debt securities. It is an officer certification/attestation rather than the substantive financial report itself. Such correspondence and regulatory compliance letters are classified under Regulatory Filings (RNS).
2026-04-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.